Anderson Hoagland & Co. Has $1,611,000 Position in Roche Holding Ltd. (RHHBY)

Anderson Hoagland & Co. maintained its stake in shares of Roche Holding Ltd. (NASDAQ:RHHBY) during the first quarter, according to its most recent disclosure with the SEC. The fund owned 50,300 shares of the company’s stock at the end of the first quarter. Anderson Hoagland & Co.’s holdings in Roche Holding were worth $1,611,000 as of its most recent filing with the SEC.

Other hedge funds have also recently made changes to their positions in the company. Taylor Cottrill Erickson & Associates Inc. increased its position in shares of Roche Holding by 0.7% in the third quarter. Taylor Cottrill Erickson & Associates Inc. now owns 34,020 shares of the company’s stock worth $1,054,000 after buying an additional 250 shares during the period. Dempze Nancy E increased its position in shares of Roche Holding by 1.5% in the third quarter. Dempze Nancy E now owns 23,365 shares of the company’s stock worth $724,000 after buying an additional 335 shares during the period. Fayerweather Charles increased its position in shares of Roche Holding by 2.7% in the third quarter. Fayerweather Charles now owns 13,599 shares of the company’s stock worth $420,000 after buying an additional 359 shares during the period. New England Research & Management Inc. increased its position in shares of Roche Holding by 5.1% in the first quarter. New England Research & Management Inc. now owns 16,127 shares of the company’s stock worth $517,000 after buying an additional 777 shares during the period. Finally, Cadence Bank NA increased its position in shares of Roche Holding by 11.5% in the fourth quarter. Cadence Bank NA now owns 8,718 shares of the company’s stock worth $249,000 after buying an additional 901 shares during the period.

Institutional Ownership by Quarter for Roche Holding (NASDAQ:RHHBY)

Shares of Roche Holding Ltd. (NASDAQ:RHHBY) traded down 0.164% during midday trading on Thursday, reaching $31.748. The company’s stock had a trading volume of 585,052 shares. Roche Holding Ltd. has a 12-month low of $25.25 and a 12-month high of $33.77. The company has a market capitalization of $216.38 billion and a P/E ratio of 22.935. The company’s 50-day moving average price is $31.94 and its 200 day moving average price is $29.86.

ILLEGAL ACTIVITY WARNING: “Anderson Hoagland & Co. Has $1,611,000 Position in Roche Holding Ltd. (RHHBY)” was originally posted by WKRB News and is the property of of WKRB News. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at http://www.wkrb13.com/markets/2065269/anderson-hoagland-co-has-1611000-position-in-roche-holding-ltd-rhhby.html.

A number of brokerages have recently issued reports on RHHBY. Zacks Investment Research downgraded Roche Holding from a “strong-buy” rating to a “hold” rating in a research report on Thursday. HSBC Holdings plc downgraded Roche Holding from a “hold” rating to a “reduce” rating in a research report on Friday, April 7th. Cowen and Company upgraded Roche Holding from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $25.25 to $33.37 in a research report on Wednesday, April 5th. Liberum Capital began coverage on Roche Holding in a research report on Thursday, March 9th. They set a “hold” rating for the company. Finally, Barclays PLC began coverage on Roche Holding in a research report on Tuesday, March 7th. They set an “overweight” rating for the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $34.69.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

5 Day Chart for NASDAQ:RHHBY

Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding Ltd. (NASDAQ:RHHBY).

This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2065269/anderson-hoagland-co-has-1611000-position-in-roche-holding-ltd-rhhby.html

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.